Your browser doesn't support javascript.
loading
Correction to: A randomized, open-label, adaptive, proof-of-concept clinical trial of modulation of host thromboinflammatory response in patients with COVID-19: the DAWn-Antico study.
Vanassche, T; Engelen, M M; Van Thillo, Q; Wauters, J; Gunst, J; Wouters, C; Vandenbriele, C; Rex, S; Liesenborghs, L; Wilmer, A; Meersseman, P; Van den Berghe, G; Dauwe, D; Verbeke, G; Thomeer, M; Fivez, T; Mesotten, D; Ruttens, D; Heytens, L; Dapper, I; Tuyls, S; De Tavernier, B; Verhamme, P.
Afiliación
  • Vanassche T; Center for Molecular and Vascular Biology, KU Leuven Department of Cardiovascular Sciences, KU Leuven, Leuven, Belgium. thomas.vanassche@uzleuven.be.
  • Engelen MM; Department of Cardiovascular Sciences, University Hospitals Leuven, Leuven, Belgium. thomas.vanassche@uzleuven.be.
  • Van Thillo Q; Center for Molecular and Vascular Biology, KU Leuven Department of Cardiovascular Sciences, KU Leuven, Leuven, Belgium.
  • Wauters J; Department of Cardiovascular Sciences, University Hospitals Leuven, Leuven, Belgium.
  • Gunst J; Center for Cancer Biology, VIB, Leuven, Belgium.
  • Wouters C; Department of General Internal Medicine, Medical Intensive Care Unit, University Hospitals Leuven, Leuven, Belgium.
  • Vandenbriele C; Clinical Department and Laboratory of Intensive Care Medicine, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium.
  • Rex S; Pediatric Rheumatology, University Hospitals Leuven, Leuven, Belgium.
  • Liesenborghs L; Laboratory of Adaptive Immunology & Immunobiology, Department of Microbiology and Immunology, KU Leuven, Leuven, Belgium.
  • Wilmer A; Center for Molecular and Vascular Biology, KU Leuven Department of Cardiovascular Sciences, KU Leuven, Leuven, Belgium.
  • Meersseman P; Department of Cardiovascular Sciences, University Hospitals Leuven, Leuven, Belgium.
  • Van den Berghe G; Department of Cardiovascular Sciences, University Hospitals Leuven, Leuven, Belgium.
  • Dauwe D; Department of Anesthesiology, University Hospitals Leuven, Leuven, Belgium.
  • Verbeke G; Center for Molecular and Vascular Biology, KU Leuven Department of Cardiovascular Sciences, KU Leuven, Leuven, Belgium.
  • Thomeer M; REGA Institute, KU Leuven, Leuven, Belgium.
  • Fivez T; Department of General Internal Medicine, Medical Intensive Care Unit, University Hospitals Leuven, Leuven, Belgium.
  • Mesotten D; Department of General Internal Medicine, Medical Intensive Care Unit, University Hospitals Leuven, Leuven, Belgium.
  • Ruttens D; Clinical Department and Laboratory of Intensive Care Medicine, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium.
  • Heytens L; Clinical Department and Laboratory of Intensive Care Medicine, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium.
  • Dapper I; Interuniversity Institute for Biostatistics and statistical Bioinformatics (I-BioStat), KU Leuven, Leuven, and Hasselt University (UHasselt), Hasselt, Belgium.
  • Tuyls S; Department of Respiratory Medicine, Ziekenhuis Oost-Limburg, Genk, Belgium.
  • De Tavernier B; Department of Medicine and Life Sciences, Hasselt University, Diepenbeek, Belgium.
  • Verhamme P; Department of Medicine and Life Sciences, Hasselt University, Diepenbeek, Belgium.
Trials ; 21(1): 1033, 2020 Dec 29.
Article en En | MEDLINE | ID: mdl-33375932
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Trials Asunto de la revista: MEDICINA / TERAPEUTICA Año: 2020 Tipo del documento: Article País de afiliación: Bélgica Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Trials Asunto de la revista: MEDICINA / TERAPEUTICA Año: 2020 Tipo del documento: Article País de afiliación: Bélgica Pais de publicación: Reino Unido